Steven T. Merkt - Jan 4, 2024 Form 4 Insider Report for Livent Corp. (LTHM)

Role: Director
Signature: /s/ Sara Ponessa, as attorney-in-fact
Stock symbol: LTHM
Transactions as of: Jan 4, 2024
Transactions value $: $0
Form type: 4
Date filed: 1/8/2024, 04:08 PM
Previous filing: Dec 13, 2023
Next filing: Jan 30, 2024

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	LTHM	Common Stock	Disposed to Issuer		-500	-100%		0	Jan 4, 2024	Direct	F1
transaction	LTHM	Common Stock	Disposed to Issuer		-49K	-100%		0	Jan 4, 2024	Direct	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Steven T. Merkt is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may continue.

Explanation of Responses:

Id	Content
F1	Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")).
F2	Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement).

Content

Represents the conversion of each share of common stock of the Livent Corporation ("Livent"), par value $0.001 per share ("Livent Common Stock"), held by the reporting person as of January 4, 2024, into the right to receive a number of validly issued, fully paid and non-assessable ordinary shares of Arcadium Lithium plc ("Arcadium"), par value $1.00 each ("Arcadium Shares") equal to the Merger Exchange Ratio (as defined in the Transaction Agreement, dated as of May 10, 2023, by and between Livent, Allkem Limited ("Allkem"), Lightning-A Merger Sub, Inc. and Arcadium, providing for a combination of Livent and Allkem in a merger of equals transaction (the "Transaction Agreement")).

Represents the cancellation and conversion of restricted stock units ("Livent RSUs") with respect to shares of Livent Common Stock, held by the reporting person as of January 4, 2024, into an amount of cash equal to (i) the number of shares of Livent Common Stock subject to such Livent RSUs immediately prior to the Effective Time of the merger (as defined in the Transaction Agreement), multiplied by (ii) the higher of (A) the first available closing price of the Merger Consideration (as defined in the Transaction Agreement) and (B) the closing price per share of Livent Common Stock as reported in the New York Stock Exchange, on the last trading day preceding the Closing Date of the merger (as defined in the Transaction Agreement).